More Articles
Vitamin D is a fat soluble vitamin that is essential for maintaining bone health and also has other potential health benefits. While some of these other health benefits are not…
Levothyroxine sodium oral solution (Tirosint-SOL) has now been approved by the FDA and is available for use in the US. Please click on the link below for details regarding the product…
Overview
The FDA recently approved a Safety Labeling Change (SLC) addressing the risk of necrolytic migratory erythema (NME) with continuous intravenous glucagon use. This change has been made because of case reports of NME, including three pediatric and three adult cases. All of the pediatric cases were also reported to the FDA Adverse Event Reporting System (FAERS). The first citation below contains two of the pediatric cases. One adult case (Mullans, et al.) was only available from the literature; the other two adult cases were also reported to FAERS. The FDA does not know the incidence of NME nor the incidence of off-label use of glucagon.
For the full wording of the label change, please log in.
Not a member?
On January 18, 2018, the Trump administration announced it would be creating a “Division of Conscience and Religious Freedom” at the Department of Health and Human Services. This new office…
The Special Diabetes Program (SDP) supports research to prevent, treat, and cure type 1 diabetes and its complications and type 2 diabetes treatment and prevention strategies for American Indian and…
Media Release: Updated Information About Safety Events after Gonadotropin Releasing Hormone Agonist Therapy. 3/21/17 Dear Colleagues, On 2/2/17, Kaiser Health News published an article raising concerns about potential long-term side…
We are pleased to note that with unanimous approval of our Board of Directors, PES (in addition to other professional societies and academic centers in the U.S.) signed on to…
The House and Senate have been negotiating a large, bipartisan mental health package over much of the past year. The most recent draft of this package in the House (H.R.…
The most recent version of the 2017 National Defense Authorization Act (NDAA) (S.2943) has the potential to eliminate certain health care providers from the Military Health System. This includes Pediatricians,…
Click here to view the final coalition letter signed by 70 medical, public health, and patient organizations endorsing the Ensuring Children’s Access to Specialty Care Act (H.R. 1859/S. 2782).
